loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering Osimertinib Mesylate

    Client Email Product
    Menu

    Osimertinib Mesylate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ASTRAZENECA (20)

    filter

    01 8946235 (6)

    02 9732058 (6)

    03 10183020 (6)

    04 11524951 (2)

    filter

    01 Y (14)

    02 Blank (6)

    filter

    01 Y (20)

    filter

    01 2032-07-25 (8)

    02 2032-08-08 (6)

    03 2035-01-02 (6)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    9732058
    Y
    Y
    2032-07-25
    U-1777
    208065
    TREATMENT OF PATIENTS WITH METASTATIC EPIDERMAL GROWTH FACTORE RECEPTOR (EGFR) T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC), WHO HAVE PR
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    9732058
    Y
    Y
    2032-07-25
    U-1777
    208065
    TREATMENT OF PATIENTS WITH METASTATIC EPIDERMAL GROWTH FACTORE RECEPTOR (EGFR) T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC), WHO HAVE PR
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    8946235
    Y
    Y
    2032-08-08
    U-1777
    208065
    TREATMENT OF PATIENTS WITH METASTATIC EPIDERMAL GROWTH FACTORE RECEPTOR (EGFR) T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC), WHO HAVE PR
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    10183020
    Y
    2035-01-02
    U-1777
    208065
    TREATMENT OF PATIENTS WITH METASTATIC EPIDERMAL GROWTH FACTORE RECEPTOR (EGFR) T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC), WHO HAVE PR
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    10183020
    Y
    2035-01-02
    U-1777
    208065
    TREATMENT OF PATIENTS WITH METASTATIC EPIDERMAL GROWTH FACTORE RECEPTOR (EGFR) T790M MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC), WHO HAVE PR
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    10183020
    Y
    2035-01-02
    U-2289
    208065
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    9732058
    Y
    Y
    2032-07-25
    U-2289
    208065
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    9732058
    Y
    Y
    2032-07-25
    U-2289
    208065
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    8946235
    Y
    Y
    2032-08-08
    U-2289
    208065
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OSIMERTINIB MESYLATE

    PDF Supplier PDF
    URL Supplier Web Content
    8946235
    Y
    Y
    2032-08-08
    U-2289
    208065
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY